Dublin, March 13, 2018 -- The "Global Dental Partnering 2012-2018: Deal trends, players and financials" report has been added to ResearchAndMarkets.com's offering.
Global Dental Partnering 2012 to 2018 provides the full collection of Dental disease deals signed between the world's pharmaceutical and biotechnology companies since 2012.
Most of the deals included within the report occur when a licensee obtains a right or an option right to license a licensor's product or technology. More often these days these deals tend to be multi-component including both a collaborative R&D and a commercialization of outcomes element.
The report takes readers through the comprehensive Dental disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering Dental deals.
The report presents financial deal terms values for Dental deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers to analyse and benchmark the value of current deals.
The initial chapters of this report provide an orientation of Dental dealmaking trends.
In addition, a comprehensive appendix is provided with each report of all Dental partnering deals signed and announced since 2012. The appendices are organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc) and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.
In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of Dental technologies and products.
Key Topics Covered:
Executive Summary
Chapter 1 - Introduction
Chapter 2 - Trends in Dental dealmaking
2.1. Introduction
2.2. Dental partnering over the years
2.3. Dental partnering by deal type
2.4. Dental partnering by industry sector
2.5. Dental partnering by stage of development
2.6. Dental partnering by technology type
2.7. Dental partnering by therapeutic indication
Chapter 3 - Financial deal terms for Dental partnering
3.1. Introduction
3.2. Disclosed financials terms for Dental partnering
3.3. Dental partnering headline values
3.4. Dental deal upfront payments
3.5. Dental deal milestone payments
3.6. Dental royalty rates
Chapter 4 - Leading Dental deals and dealmakers
4.1. Introduction
4.2. Most active in Dental partnering
4.3. List of most active dealmakers in Dental
4.4. Top Dental deals by value
Chapter 5 - Dental contract document directory
5.1. Introduction
5.2. Dental partnering deals where contract document available
Chapter 6 - Dental dealmaking by therapeutic target
6.1. Introduction
6.2. Deals by Dental therapeutic target
For more information about this report visit https://www.researchandmarkets.com/research/q73txg/global_dental?w=12
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Dental


Siemens Energy Q3 Profit Beats Forecast as AI-Driven Power Demand Fuels Growth
Airbnb Stock Jumps After Q2 Earnings Beat, Strong 2026 Outlook
Samsung, SK Hynix Test AMEC Chipmaking Tools for China Backup Plan
SK Hynix, Samsung Lead Asian Chip Stock Selloff After Sandisk, Western Digital Outlook
SpaceX Targets Starship Flight 14 With First V3 Starlink Satellite Launch
Alibaba Plans Revenue-Sharing Model for Qwen3.8-Max AI Commercial Users
Cloudflare Stock Jumps 15% as Earnings Beat Estimates, 2026 Outlook Raised
SanDisk Q4 Earnings Beat Estimates as Q1 Revenue Outlook Meets Expectations
Heineken H1 Operating Profit Meets Forecast as Beer Volumes Beat Expectations
DoorDash Q2 Revenue Jumps 36% as Orders and DashPass Growth Drive Results
Meta Ordered to Pay $567M Over Child Safety Violations in New Mexico
Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+
Nintendo Shares Jump as Switch 2 Sales Boost Earnings
AMP Shares Surge 13% After Strong Profit and A$150 Million Buyback
Western Digital Q4 Earnings Beat Estimates as FY2027 Outlook Tops Expectations
Novo Nordisk Raises 2025 Outlook Despite Wegovy Pill Miss and CagriSema Setback
Jetstar to Charge for Overhead Cabin Bags From February 



